GDTC
CytoMed Therapeutics Limited Ordinary Shares
$2.135+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.135
High
$2.135
Low
$2.135
Volume
0.00M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or the "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.